NASDAQ · Biotechnology

Liquidia Corporation (LQDA) Stock

$27.38 -2.28% NASDAQ: LQDA Healthcare

Valuation

MetricValue
Price$27.38
Market Cap$2.43B
P/E Ratio19.28
P/B Ratio13.79
P/S Ratio5.97
EPS (TTM)$-0.80
52-Week High$93.61
52-Week Low$21.35
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE149.64%
ROA26.56%
ROCE50.68%
Gross Margin98.72%
Operating Margin15.81%
Net Margin30.74%
Debt/Equity0.66
Current Ratio2.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$16.0M$17.0M$14.0M$158.0M
Operating Profit$-34.0M$-39.0M$-73.0M$-121.0M$-51.0M
Net Profit$-35.0M$-41.0M$-79.0M$-130.0M$-69.0M
EPS$-0.70$-0.67$-1.21$-1.66$-0.80
Op Margin-262.9%-243.3%-419.6%-866.6%-32.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$94.0M$129.0M$118.0M$230.0M$328.0M
Total Liabilities$28.0M$39.0M$71.0M$153.0M$283.0M
Cash$57.0M$93.0M$84.0M$176.0M$191.0M
Borrowings$16.0M$24.0M$50.0M$122.0M$198.0M

Latest News

Here's Why You Should Add INKT Stock to Your Portfolio Now Zacks · Jul 16, 2026 Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance Zacks · Jul 16, 2026 Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal Zacks · Jul 15, 2026 Liquidia Insider Sold Shares Worth $2,520,683, According to a Recent SEC Filing MT Newswires · Jul 15, 2026 Liquidia Insider Sold Shares Worth $1,460,965, According to a Recent SEC Filing MT Newswires · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-29.0M$-42.0M$-93.0M$-36.0M
Investing Cash Flow$0$-1.0M$-13.0M$-13.0M$-11.0M
Financing Cash Flow$5.0M$2.0M$0$4.0M$1.0M
Net Cash Flow$-8.0M$36.0M$-10.0M$93.0M$14.0M
Free Cash Flow$-34.0M$-29.0M$-43.0M$-98.0M$-40.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA14.26
FCF Yield2.25%
Quick Ratio2.12
Interest Coverage6.33
Return 1Y138.07%
Return 3Y882.26%
Return 5Y2443.07%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVLNAvalyn Pharma Inc. $25.76 +0.16% -19.97 $1.14B 0.00%
INSMInsmed Incorporated $100.60 +0.12% -28.13 $21.81B 0.00%
UTHRUnited Therapeutics Corporation $549.16 +3.07% 17.74 $23.31B 0.00%
VCREVicore Pharma Holding AB $8.82 +1.85% -9.33 $2.48B 0.00%

About Liquidia Corporation

Liquidia Corporation is led by CEO Roger A. Jeffs, employs 216 people, headquartered in Morrisville, US, publicly traded since 2018.

Liquidia Corporation (LQDA) stock trades at $27.38 with a market capitalization of $2.43B. The stock is valued at a price-to-earnings (P/E) ratio of 19.28, price-to-book of 13.79, price-to-sales of 5.97. Over the past 52 weeks the stock has ranged between $21.35 and $93.61, and currently trades 70.8% below its 52-week high.

On profitability, Liquidia Corporation generates a return on equity (ROE) of 149.64% — well above the market average, a sign of a high-quality business, return on capital employed of 50.68%, an operating margin of 15.81%, a net profit margin of 30.74%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides